Subscribe to Search results
FDA recommendation of steps including avoiding use of high risk plasma in US blood products was published.
Published on:
Paper from Dr Spence Galbraith recommended suspending importation of US blood products.
Published on:
CSM(B) decided not to recommend action to stop continued importation of commercial concentrates.
Published on:
It was confirmed that import of factor products made from higher risk pre-March plasma would continue.
Published on:
Dr Walford wrote in a DHSS minute that NANBH could "be rapidly fatal" and "lead to progressive liver damage".
Published on:
The line "no conclusive proof" first appeared in a briefing note to the Prime Minister.
Published on: